Secondary Malignancies After Autologous Stem Cell Transplantations in Patients With Malignant Lymphoma and Multiple Myeloma
Secondary malignancies after ASCT are relatively frequent complications. Our findings suggest that systematic life-long cancer screening after ASCT is essential to improve the prognosis of these adverse events.
Authors
- Andreas Voß (ORCID: https://orcid.org/0000-0001-9647-5024)
- Bernd Metzner (ORCID: https://orcid.org/0000-0002-1496-1377)
- Ruth Thole
- Christoph Kimmich
- Thomas Müller (ORCID: https://orcid.org/0000-0002-5417-6787)
- Eduard K. Petershofen
- Jochen Casper
- Claus Henning Köhne
Institutions
- German Red Cross (DE)
- Klinikum Oldenburg (DE)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1111/ejh.14355
- Citations
- 5
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.27